BDSX
Biodesix Inc
NASDAQ: BDSX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.32
-0.97% today
Updated 2026-05-08
Market cap
$113.91M
P/E ratio
—
P/S ratio
1.29x
EPS (TTM)
$-4.75
Dividend yield
—
52W range
$3 – $20
Volume
0.1M
Biodesix Inc (BDSX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-39.90%
Operating margin
-6.84%
ROE
-383.10%
ROA
-18.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $20.43M | $-26.17M | 78.44% | -114.82% | -128.06% |
| 2019 | $24.55M | $-30.73M | 75.26% | -108.92% | -125.15% |
| 2020 | $45.56M | $-31.35M | 51.71% | -50.34% | -68.81% |
| 2021 | $54.51M | $-43.16M | 44.01% | -75.11% | -79.18% |
| 2022 | $38.21M | $-65.45M | 62.96% | -132.39% | -171.27% |
| 2023 | $49.09M | $-52.15M | 73.50% | -84.22% | -106.23% |
| 2024 | $71.32M | $-42.93M | 78.17% | -48.37% | -60.19% |
| 2025 | $88.50M | $-35.27M | 75.25% | -31.50% | -39.85% |